Tekla Capital Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Tekla Capital Management’s Portfolio JNCE Stock Details JNCE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell
2021 Q2	$2.6M	Hold
2021 Q1	$3.93M	Buy
2019 Q2	–	Sell
2019 Q1	$63K	Hold
2018 Q4	$34K	Hold
2018 Q3	$66K	Hold
2018 Q2	$78K	Hold
2018 Q1	$226K	Buy